Department of Pharmacy, Affiliated Psychological Hospital of Anhui Medical University, Hefei 230000, China; Psychopharmacology Research Laboratory, Anhui Mental Health Center, Hefei 230000, China; Department of Pharmacy, Hefei Fourth People's Hospital, Hefei 230000, China; Anhui Clinical Research Center for Mental Disorders, Hefei 230000, China.
Department of Pharmacy, Affiliated Psychological Hospital of Anhui Medical University, Hefei 230000, China; Psychopharmacology Research Laboratory, Anhui Mental Health Center, Hefei 230000, China; Department of Pharmacy, Hefei Fourth People's Hospital, Hefei 230000, China; Anhui Clinical Research Center for Mental Disorders, Hefei 230000, China.
Life Sci. 2024 Aug 15;351:122820. doi: 10.1016/j.lfs.2024.122820. Epub 2024 Jun 8.
Alcohol use disorder (AUD) is a common mental illness with high morbidity and disability. The discovery of laboratory biomarkers has progressed slowly, resulting in suboptimal diagnosis and treatment of AUD. This study aimed to identify promising biomarkers, as well as the potential miRNA-mRNA networks associated with AUD pathogenesis. RNA sequencing was performed on plasma-derived small extracellular vesicles (sEVs) from AUD patients and healthy controls (HCs) to harvest miRNAs expression profiles. Machine learning (ML) models were built to screen characteristic miRNAs, whose target mRNAs were analyzed using TargetScan, miRanda and miRDB databases. Gene Expression Omnibus (GEO) datasets (GSE181804 and GSE180722) providing postmortem hippocampal gene expression profiles of AUD subjects were mined. A total of 247 differentially expressed (DE) plasma-derived sEVs miRNAs and 122 DE hippocampal mRNAs were obtained. Then, 22 overlapping sEVs miRNAs with high importance scores were gained by intersecting 5 ML models. As a result, we established a putative sEVs miRNA-hippocampal mRNA network that can effectively distinguish AUD patients from HCs. In conclusion, we proposed 5 AUD-representative sEVs miRNAs (hsa-miR-144-5p, hsa-miR-182-5p, hsa-miR-142-5p, hsa-miR-7-5p, and hsa-miR-15b-5p) that may participate in the pathogenesis of AUD by modulating downstream target hippocampal genes. These findings may provide novel insights into the diagnosis and treatment of AUD.
酒精使用障碍(AUD)是一种常见的精神疾病,发病率和致残率都很高。实验室生物标志物的发现进展缓慢,导致 AUD 的诊断和治疗效果不佳。本研究旨在确定有前途的生物标志物,以及与 AUD 发病机制相关的潜在 miRNA-mRNA 网络。对 AUD 患者和健康对照(HC)的血浆衍生小细胞外囊泡(sEVs)进行 RNA 测序,以获取 miRNA 表达谱。构建机器学习(ML)模型筛选特征 miRNA,使用 TargetScan、miRanda 和 miRDB 数据库分析其靶 mRNA。挖掘提供 AUD 受试者死后海马基因表达谱的基因表达综合数据库(GEO)数据集(GSE181804 和 GSE180722)。共获得 247 个差异表达(DE)的血浆衍生 sEVs miRNA 和 122 个 DE 海马 mRNA。然后,通过相交 5 个 ML 模型,获得了 22 个具有高重要性评分的重叠 sEVs miRNA。结果,我们建立了一个可以有效区分 AUD 患者和 HCs 的推定 sEVs miRNA-海马 mRNA 网络。总之,我们提出了 5 个 AUD 代表性 sEVs miRNA(hsa-miR-144-5p、hsa-miR-182-5p、hsa-miR-142-5p、hsa-miR-7-5p 和 hsa-miR-15b-5p),它们可能通过调节下游靶海马基因参与 AUD 的发病机制。这些发现可能为 AUD 的诊断和治疗提供新的思路。